成功开发治疗胃衰竭的目标
David Yi Yang1, Michael Camilleri1
1Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Neurogastroenterology and motility
|June 17, 2024
概括
开发新的胃衰竭治疗方法需要明确的目标和验证的患者结果. 本综述提出了基于证据的原则,以提高这种胃运动障碍的临床试验成功率.
科学领域:
- 胃肠病学 胃肠病学
- 运动性障碍 运动性障碍
- 临床试验设计 临床试验设计
背景情况:
- 胃衰竭是一种胃运动障碍,具有显著的未满足需求.
- 延迟的胃排空和核心症状定义了胃衰竭.
- 40多年来,没有批准用于胃的新药物.
研究的目的:
- 确定治疗目标和胃的成功标准.
- 为开发新的胃衰竭治疗提出基于证据的原则.
- 为了确定病理生理学目标,试验资格和验证的患者结果.
主要方法:
- 审查当前对胃衰竭的科学理解.
- 经过验证的胃空化研究的分析和患者反应结果的测量.
- 支持胃衰竭枢机症状指数 每日日记.
主要成果:
- 关于临床试验资格,设计和持续时间的建议.
- 缩短有效性证明试验到4周的理由.
- 提出的原则,以加强对新型胃衰竭疗法的评估.
结论:
- 标准化方法对于评估新的胃衰竭治疗方法至关重要.
- 经过验证的患者结果和试验设计改善了疗效评估.
- 这一框架旨在加速开发有效的胃衰竭疗法.
相关概念视频
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
104
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
104
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
305
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
305
01:20Gastrointestinal Motility Disorders
334
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
334
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
68
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
68
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
287
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
287
01:29Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84